Male germ cell-specific RNA binding protein RBMY: A new oncogene explaining male predominance in liver cancer

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Tsuei, Daw Jen ^a   Lee, Po Huang ^a   Peng, Hsiao Yu ^a   Lu, Shau Lin ^a   Su, De Shiuan ^a   Jeng, Yung Ming ^a   Hsu, Hey Chi ^a   Hsu, Shu Hao ^a   Wu, Jia Feng ^a   Ni, Yen Hsuan ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROGEN RECEPTOR 45 VARIANT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; RBMY1A1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO CULTURE; LIVER ADENOMA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE; PRECANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING MOTIF GENE ON Y CHROMOSOME; RNA INTERFERENCE; TESTIS CELL; TRANSGENIC MOUSE; Y CHROMOSOME; ANIMAL; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 80455150228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026948     Document Type: Article

References (33)

1. Bosch FX, Ribes J, Diaz M, Cleries R, (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
2. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
3. Yang JD, Roberts LR, (2010) Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
4. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, et al. (2000) Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 92: 2023-2028.
5. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336: 1855-1859.
6. Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, et al. (2000) Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 284: 3040-3042.
7. Kanda T, Steele R, Ray R, Ray RB, (2008) Hepatitis C virus core protein augments androgen receptor-mediated signalling. J Virol 82: 11066-11072.
8. Ruggieri A, Barbati C, Malorni W, (2010) Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer 127: 499-504.
9. Kemp CJ, Leary CN, Drinkwater NR, (1989) Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc Natl Acad Sci U S A 86: 7505-7509.
10. Peng L, Malloy PJ, Wang J, Feldman D, (2006) Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells. Endocrinology 147: 4599-4607.
11. Pandini G, Mineo R, Frasca F, Roberts CT Jr, Marcelli M, et al. (2005) Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer Res 65: 1849-1857.
12. Lee HJ, Chang C, (2003) Recent advances in androgen receptor action. Cell Mol Life Sci 60: 1613-1622.
13. Ahrens-Fath I, Politz O, Geserick C, Haendler B, (2005) Androgen receptor function is modulated by the tissue-specific AR45 variant. FEBS J 272: 74-84.
14. Chamberlain NL, Driver ED, Miesfeld RL, (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22: 3181-3186.
15. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, et al. (2009) Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50: 1392-1402.
16. Yang WJ, Chang CJ, Yeh SH, Lin WH, Wang SH, et al. (2009) Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology 49: 1515-1524.
17. Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, et al. (2010) Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2: 32ra35.
18. Tsuei DJ, Chang MH, Chen PJ, Hsu TY, Ni YH, (2002) Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas. J Med Virol 68: 513-521.
19. Yin YH, Li YY, Qiao H, Wang HC, Yang XA, et al. (2005) TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer 93: 458-463.
20. Elliott DJ, Millar MR, Oghene K, Ross A, Kiesewetter F, et al. (1997) Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci U S A 94: 3848-3853.
21. Mahadevaiah SK, Odorisio T, Elliott DJ, Rattigan A, Szot M, et al. (1998) Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids, and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities. Hum Mol Genet 7: 715-727.
22. Dreumont N, Bourgeois CF, Lejeune F, Liu Y, Ehrmann IE, et al. (2010) Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}. J Cell Sci 123: 40-50.
23. Liu Y, Bourgeois CF, Pang S, Kudla M, Dreumont N, et al. (2009) The germ cell nuclear proteins hnRNP G-T and RBMY activate a testis-specific exon. PLoS Genet 5: e1000707.
24. Tsuei DJ, Hsu HC, Lee PH, Jeng YM, Pu YS, et al. (2004) RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene 23: 5815-5822.
25. Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, et al. (2008) The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. J Pathol 215: 67-77.
26. Venables JP, Vernet C, Chew SL, Elliott DJ, Cowmeadow RB, et al. (1999) T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis. Hum Mol Genet 8: 959-969.
27. Angulo P, Lindor KD, (2002) Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 (Suppl): S186-190.
28. Fumagalli S, Totty NF, Hsuan JJ, Courtneidge SA, (1994) A target for Src in mitosis. Nature 368: 871-874.
29. Matter N, Herrlich P, Konig H, (2002) Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420: 691-695.
30. Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, et al. (2007) Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A 104: 2571-2578.
31. Mahler JF, Stokes W, Mann PC, Takaoka M, Maronpot RR, (1996) Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24: 710-716.
32. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124.
33. Prieto J, (2008) Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol 48: 380-381.